scholarly journals Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes

EP Europace ◽  
2013 ◽  
Vol 16 (2) ◽  
pp. 258-264 ◽  
Author(s):  
D. Vollmann ◽  
S. Woronowicz ◽  
L. Kmiec ◽  
K. Jung ◽  
D. Zenker ◽  
...  
2013 ◽  
Vol 168 (2) ◽  
pp. 848-852 ◽  
Author(s):  
Iftikhar A. Fazal ◽  
Ewen J. Shepherd ◽  
Margaret Tynan ◽  
Christopher J. Plummer ◽  
Janet M. McComb

Author(s):  
Hilda E. Fernandez ◽  
Bethany J. Foster

Pediatric kidney transplant recipients are distinguished from adult recipients by the need for many decades of graft function, the potential effect of CKD on neurodevelopment, and the changing immune environment of a developing human. The entire life of an individual who receives a transplant as a child is colored by their status as a transplant recipient. Not only must these young recipients negotiate all of the usual challenges of emerging adulthood (transition from school to work, romantic relationships, achieving independence from parents), but they must learn to manage a life-threatening medical condition independently. Regardless of the age at transplantation, graft failure rates are higher during adolescence and young adulthood than at any other age. All pediatric transplant recipients must pass through this high-risk period. Factors contributing to the high graft failure rates in this period include poor adherence to treatment, potentially exacerbated by the transfer of care from pediatric- to adult-oriented care providers, and perhaps an increased potency of the immune response. We describe the characteristics of pediatric kidney transplant recipients, particularly those factors that may influence their care throughout their lives. We also discuss the risks associated with the transition from pediatric- to adult-oriented care and provide some suggestions to optimize transition to adult-oriented transplant care and long-term outcomes.


EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i71-i71
Author(s):  
Thomas Kleemann ◽  
Florian Nonnenmacher ◽  
Kleopatra Kouraki ◽  
Margit Strauss ◽  
Nicolaus Werner ◽  
...  

2015 ◽  
Vol 18 (3) ◽  
pp. A156 ◽  
Author(s):  
A. Layton ◽  
R.J. Arnold ◽  
J. Graham ◽  
M.A. Frasco ◽  
E. Cote ◽  
...  
Keyword(s):  

2017 ◽  
Vol 11 (6S2) ◽  
pp. 143 ◽  
Author(s):  
Alex Kavanagh ◽  
May Sanaee ◽  
Kevin V. Carlson ◽  
Gregory G. Bailly

Surgical failure rates after midurethral sling (MUS) procedures are variable and range from approximately 8‒57% at five years of followup. The disparity in long-term failure rates is explained by a lack of long-term followup and lack of a clear definition of what constitutes failure. A recent Cochrane review illustrates that no high-quality data exists to recommend or refute any of the different management strategies for recurrent or persistent stress urinary incontinence (SUI) after failed MUS surgery. Clinical evaluation requires a complete history, physical examination, and establishment of patient goals. Conservative treatment measures include pelvic floor physiotherapy, incontinence pessary dish, commercially available devices (Uresta®, Impressa®), or medical therapy. Minimally invasive therapies include periurethral bulking agents (bladder neck injections) and sling plication. Surgical options include repeat MUS with or without mesh removal, salvage autologous fascial sling or Burch colposuspension, or salvage artificial urinary sphincter insertion. In this paper, we present the available evidence to support each of these approaches and include the management strategy used by our review panel for patients that present with SUI after failed midurethral sling.


EP Europace ◽  
2012 ◽  
Vol 14 (11) ◽  
pp. 1620-1623 ◽  
Author(s):  
S. M. Frey ◽  
C. Sticherling ◽  
U. Bucher ◽  
R. Widmer ◽  
P. Ammann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document